Literature DB >> 13718557

17alpha-Hydroxyprogesterone--a salt-losing steroid: relation to congenital adrenal hyperplasia.

D R JACOBS, J VAN DER POLL, J L GABRILOVE, L J SOFFER.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX/diseases; PROGESTERONE/related compounds

Mesh:

Substances:

Year:  1961        PMID: 13718557     DOI: 10.1210/jcem-21-8-909

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.

Authors:  A KOWARSKI; J W FINKELSTEIN; J S SPAULDING; G H HOLMAN; C J MIGEON
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

2.  Quantitative estimation of 17alpha-hydroxypregn-4-ene-3,20-dione (17alphaOH-progesterone) in adrenal venous blood and adrenal glands.

Authors:  M Holzbauer; H M Newport
Journal:  J Physiol       Date:  1968-09       Impact factor: 5.182

3.  Congenital adrenal hyperplasia: renin and steroid values during treatment.

Authors:  D B Grant; M J Dillon; S M Atherden; R J Levinsky
Journal:  Eur J Pediatr       Date:  1977-08-23       Impact factor: 3.183

4.  Evaluation of deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

Authors:  O M Galal; B T Rudd; N M Drayer
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

Review 5.  The adrenal cortex in childhood. 2. Pathological aspects.

Authors:  H K Visser
Journal:  Arch Dis Child       Date:  1966-04       Impact factor: 3.791

6.  Congenital adrenal hyperplasia due to combined 21- and 11 beta-hydroxylase deficiency.

Authors:  R Penny; P Vecsei
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

7.  Plasma renin activity in the management of congenital adrenal hyperplasia.

Authors:  K D Griffiths; J M Anderson; B T Rudd; N K Virdi; G Holder; P H Rayner
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

8.  Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia.

Authors:  F C Bartter; R I Henkin; G T Bryan
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.